Glycologix
About:
Glycologix is a biotechnology company that specializes in R&D of biomaterials for the protection and repair of soft tissues.
Website: http://www.glycologix.com/
Top Investors: Cortado Ventures
Description:
Glycologix is a biotechnology company that focuses on locally delivered biopolymers for soft tissue protection. Replenishing naturally occurring proteoglycans can help with a variety of unmet medical conditions. Its platform discovery engine makes it possible to create synthetic structural mimics of proteoglycans. These novel materials are highly soluble despite their high molecular weight, allowing for optimal tissue coverage. Interstitial cystitis, dry eye, post-surgical adhesion prevention, osteoarthritis, spinal disk disease, and wound repair are among the platform's targeted indications.
$4.4M
$1M to $10M
Beverly, Massachusetts, United States
2016-01-01
info(AT)glycologix.com
Thomas H. Jozefiak
1-10
2024-04-05
Private
© 2025 bioDAO.ai